An Ecological Systems Framework for Professional Resilience in Social Work Practice.

The cumulative effects of chronic work-related stress pervasively and persistently affect the well-being of the human services workforce. As a preventive measure, the ongoing commitment to self-care strategies and resources is essential in maintaining a healthy and resilient professional quality of life. This article describes a holistic approach to cultivating professional resilience through the ongoing practice of self-care.

Clinician Responses to Client Traumas: A Chronological Review of Constructs and Terminology.

This paper presents a chronologically-organized review of various concepts and constructs in the literature describing professional burnout, compassion fatigue, secondary traumatic stress reactions, as well as other related terms and constructs that have been used to describe these experiences among clinical practitioners and other social service professionals. A timeline will provide a graphic illustration of the historical relationships between the concepts under examination. This paper begins with a review of practitioner-related stress that primarily results from interaction with clients, followed by an examination of professional burnout, which is thought to result largely from environmentally-related issues.

A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans.

Objective: Preclinical and clinical studies demonstrate a hyperactivity of the norepinephrine system in patients with posttraumatic stress disorder (PTSD). a(2) adrenergic agonists have been shown to ameliorate symptoms of PTSD, likely because of their ability to dampen noradrenergic tone. This study tests the ability of the a(2) adrenergic agonist, guanfacine, to reduce the symptoms of PTSD.

Long-term pharmacotherapy for post-traumatic stress disorder.

This article reviews the literature on the long-term pharmacological treatment of post-traumatic stress disorder (PTSD). A PUBMED search was conducted; only studies on the effects of long-term (>14-weeks) pharmacological treatment for PTSD in adults or children were considered. Our search identified three randomised, double-blind, placebo-controlled studies (one each for sertraline, fluoxetine and risperidone), four open-label studies (one each for sertraline, paroxetine, nefazodone and valproate), one retrospective case series (clozapine) and one pooled analysis (sertraline).

Divalproex for the treatment of posttraumatic stress disorder: a retrospective chart review.

Objective. Open label trials of divalproex in the treatment of posttraumatic stress disorder (PTSD) show positive results. The objective of this study was to examine the therapeutic effects of divalproex in a larger naturalistic sample of patients with PTSD.